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Abstract: Purpose: In this review, potential benefits of oral ginger for prevention or management of drug- induced 
nausea and vomiting were evaluated based on the available evidences. 
Method: By searching medical resources including Scopus, PubMed, Medline, Cochrane central register of controlled 
trials and Cochrane database systematic reviews, available evidences were collected. Ginger, zingiber, nausea and 
vomiting were considered as keywords. 
Results and Conclusion: Various studies have evaluated effects of ginger in prevention and management of nausea and 
vomiting in different conditions such as pregnancy, chemotherapy, and post-operation. Evidences regarding anti-emetic 
effect of ginger in prevention and treatment of chemotherapy induced nausea and vomiting are limited and results are 
conflicting. More randomized clinical trials should be conducted to confirm efficacy of ginger in this regards. Ginger 
showed promising and attractive effects in preventing post-operative nausea and vomiting at least as add-on therapy. The 
exact role of ginger as anti-emetic in prevention of post- operative nausea and vomiting can be elucidated by future 
randomized clinical trials.  
Keywords: Drugs, ginger, nausea, vomiting. 
INTRODUCTION 
 Powdered rhizome of ginger (Zingiber officinale), an 
ancient food product, has been used as a traditional herbal 
medicine for alleviating nausea and vomiting. Ginger also 
has antioxidant, anti-microbial, anti-fungal, anti-neoplastic, 
anti-thrombotic, anti-diabetic, anti-hyperlipidemic, and anti-
hypertensive properties [1, 2]. Concomitant infusion of 
ginger and chemotherapy agents can increase the efficacy 
and decrease the adverse effects of these agents [3]. The 
synergistic effects of ginger and nifedipine on the inhibition 
of platelet aggregation have also been reported [2]. Gingerol 
is the main pungent ketone of ginger. The exact anti-emetic 
mechanism of gingerol has not been fully described. 
Inhibitory effects of gingerol on cholinergic (M3), 
serotonergic (5-HT3 and 5-HT4), dopamine (DA), substance 
P, and NK1 receptors at peripheral and central levels have 
been suggested as probable mechanisms [4-9]. In an 
experimental study, Qian et al. investigated the anti-emetic 
mechanism of gingerol in minks. They induced vomiting in 
minks by cisplatin. Gingerol inhibited cisplatin-induced 
vomiting through inhibition of 5-HT and DA receptors and 
reduction in expression of substance P in postrema area of 
medullary and ileum [8]. In another experimental study in 
minks, they showed reduction of substance P and NK1 
receptors at peripheral and central levels following gingerol  
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administration [7]. Pertz et al. investigated gingerol effects 
on M3 and 5-HT3 receptors in guinea pig and 5-HT4 receptor 
in rat. They showed weak inhibitory properties of gingerol at 
M3 and 5-HT3 receptors. Gingerol did not show prokinetic 
properties via stimulation of 5-HT4 receptors [6].  
 Following determination of probable mechanisms of anti-
emetic agents and considering safety issues, ginger has been 
considered as a beneficial herbal product against nausea and 
vomiting in different clinical conditions. It has been used for 
relieving of pregnancy-induced nausea and vomiting in some 
studies [10, 11]. Ginger also showed positive effects in the 
prevention and treatment of postoperative nausea and 
vomiting (PONV) and chemotherapy-induced nausea and 
vomiting (CINV) [1, 12-15].  
 Compared with conventional anti-emetic drugs, adverse 
effects of ginger are usually mild and have been reported as 
heartburn, diarrhea, and mouth irritation [4]. Limited drug 
interactions have been reported with ginger. However, 
clinically significant interaction has been reported in patients 
under concomitant treatment of warfarin and high dose of 
ginger. Ginger caused prolongation of International 
Normalized Ratio (INR) in these patients. INR should be 
monitored due to anti-platelet effect of ginger [1, 5]. 
 Evidence regarding potential benefits of oral ginger for 
prevention or management of drug-induced nausea and 
vomiting have been collected and discussed in this review.  
METHOD 
 By searching medical resources including Scopus, 
PubMed, Medline, Cochrane central register of controlled 
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trials and Cochrane database systematic reviews, available 
relevant evidences were collected. “Ginger”, “zingiber”, 
“nausea and vomiting” were considered as keywords. 
Studies investigated the effects of ginger in the prevention 
and/or treatment of drug-induced nausea and vomiting were 
included. No time limit was considered for selecting articles. 
Animal and in-vitro studies and non-English language 
reports were excluded. Finally, 20 relevant human studies 
have been reviewed. All studies have been summarized in 
Table 1. 
RESULTS  
Chemotherapy-Induced Nausea and Vomiting 
 Nausea and vomiting after chemotherapy are common 
complaints of patients. Up to 90% of individuals received 
chemotherapy agents experienced nausea and vomiting. 
CINV has negative effects on patients’ daily function and 
quality of life. Emesis is a physiologic defense following 
chemotherapy to protect gastrointestinal tract from toxins. 
CINV occurs in the first 24 hours and later after 
chemotherapy is defined as acute and delayed phases, 
respectively. Anti-emetic agents should be started at acute 
phase of the first cycle of chemotherapy because occurrence 
of CINV in this phase can increase risk of CINV in delayed 
phase and subsequent chemotherapy cycles [16]. Several 
neurotransmitters and their receptors including serotonin,  
5-HT3, 5-HT4, dopamine, substance P, and NK1 play important 
role in CINV. Different strategies are used for relieving 
CINV [12]. Serotonin receptor antagonists (e.g. ondansetron), 
corticosteroids (e.g. dexamethasone), dopamine receptor 
antagonists (e.g. domperidone), dual dopamine and serotonin 
receptors antagonists, and NK1 receptors blockers (e.g. 
aprepitant) have been proposed for management of CINV 
[12, 17].  
 The effects of ginger on controlling CINV have been 
investigated in a number of clinical trials. In a systematic 
review published in 2000, the beneficial effect of ginger in 
the management of nausea and vomiting was investigated. 
Eight randomized clinical trials met the inclusion criteria and 
three and one of them were related to PONV and CINV, 
respectively. Although a reasonable conclusion was not 
provided in this review, but it was reported that ginger 
showed a promising role in most relevant clinical conditions 
[18].  
 Sontakke et al. in 2003 reported the result of  
a randomized, cross-over, double-blind, clinical trial in  
50 patients received low dose cyclophosphamide in 
combination with other chemotherapy agents. The 
participants randomly received three regimens. First regimen 
consisted of two capsule of ginger orally (each capsule 
contained 250 mg powdered ginger) and 2ml of normal 
saline intravenously (i.v.) administered 20 minutes (min) 
before chemotherapy and then the dose of ginger was 
repeated 6 hour (h) after chemotherapy. Second regimen 
included two capsule of lactulose orally and 20 mg 
metoclopamide i.v. given 20 min before chemotherapy and 
then two capsule of metoclopramide (5 mg) 6h after 
chemotherapy. Third regimen comprising two capsule of 
lactulose orally and 4mg ondansetron i.v. administered  
 
20 min before chemotherapy and then two capsule of 
ondansetron (4 mg) 6h after chemotherapy. Participants were 
monitored for 24h after chemotherapy and then crossed -over 
for the two subsequent cycles. Severity of nausea and 
vomiting were assessed subjectively in this study. Control of 
nausea and vomiting were graded as complete, partial, or no-
response. Ginger was effective as metoclopamide in the 
control of nausea and vomiting but the efficacy of 
ondansetron was more than both ginger and metoclopramide 
[19].  
 Manusirivithaya et al. (2004) evaluated the anti-emetic 
effects of ginger on acute and delayed phases of CINV in a 
randomized, cross over, double-blind study. Forty three 
patients with cancer received cisplatin-based chemotherapy 
have been recruited. All participants received standard anti-
emetic regimen in the day one of chemotherapy. In addition, 
two capsules of ginger (regimen A) or placebo (regimen B) 
were administered 30 min before chemotherapy and then one 
ginger capsule or placebo at 6 h and 12 h after chemotherapy 
for all patients. Consequently, ginger (regimen A) or 
metoclopramide (regimen B) as one capsule four times a day 
was taken on days 2 to 5. Each capsule of ginger, 
metoclopramide, and placebo contained 250 mg powdered 
ginger, 10 mg metoclopramide, and corn starch, respectively. 
Following this phase, patients were crossed-over to other 
regimens in the subsequent cycle of chemotherapy and 
monitored for 5 days. Nausea was assessed by 10-cm visual 
analog scales and frequency of vomiting was recorded. 
Addition of ginger to standard anti-emetic regimen did not 
show further benefits in reducing CINV in the acute phase of 
chemotherapy. Furthermore, efficacy of ginger and 
metoclopramide in the delayed phase of CINV was not 
significantly different [20].  
 Effects of protein and ginger in the control of delayed 
phase of nausea after chemotherapy were evaluated  
in a randomized study. Twenty eight patients received 
chemotherapy for the first time were recruited by Levine et al. 
(2008). Participants were divided into 3 groups. Control 
group received normal diet. Protein group received protein 
drink and four capsules (250 mg) of ginger twice a day. High 
protein group received protein drink and additional protein 
and four capsules of ginger twice a day. These regimens 
were administered from days 2 to 4 following chemotherapy. 
Patients were educated to record frequency of nausea and use 
of any anti-emetic agents. High protein meals and ginger 
reduced the rate of delayed phase CINV and also anti-
emetics requirement [21].  
 Zick et al. (2009) investigated the efficacy of ginger for 
controlling acute and delayed phases of CINV in a 
randomized, double-blind clinical trial. In this study, 162 
patients received multiple-day chemotherapy were included. 
Individuals were randomized to receive one of the following 
three regimens. Regimen one was 1 g ginger (as two capsules) 
and two capsules of placebo twice daily for 3 days; regimen 
two included 2 g ginger (as four capsules) twice daily for 3 
days and regimen three consisted of four capsules of placebo 
twice daily for 3 days. Each capsule of ginger contained 250 
mg ginger extract and each capsule of placebo contained 
lactulose. The first dose of the above regimens was adminis-
tered within 1 h of completion of the first chemotherapy cycle. 
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Table 1. Summary of the studies that have evaluated effect of ginger in prevention and treatment of drug- induced nausea and 
vomiting. 
Type of study (Number of Subjects) Intervention Outcome (Reference) 
Chemotherapy Induced Nausea and Vomiting 
Systematic Review (8 Studies) Oral Ginger No Obvious Conclusion was Drawn [26] 
Randomized, cross over, double-blind, 
placebo-controlled study (n = 50) 
Regimen A: Two capsules of ginger (500 mg) orally and 2ml 
of normal saline i.v. 20 min before chemotherapy and then 500 
mg oral ginger at 6 h after chemotherapy or 
Regimen B: Two capsules of lactulose orally; metoclopamide 
(20 mg) i.v. 20 min before chemotherapy and then 
metoclopramide (5 mg) at 6 h after chemotherapy or 
Regimen C: Two capsules of lactulose orally; ondansetron (4 
mg) i.v. 20 min before chemotherapy and then two capsules of 
ondansetron (4 mg) at 6 h after chemotherapy 
Ginger was similar to metoclopamide in 
reducing nausea and vomiting but efficacy of 
ondansetron was more than ginger and 
metoclopramide [25] 
Randomized, cross over, double-blind, 
placebo-controlled study (n = 43) 
Regimen A: two capsules of ginger 30 min before 
chemotherapy, and then one capsule at 6 h and 12 h after 
chemotherapy on day one and then one capsule of ginger were 
given to patients four times a day on day 2 to 5 or 
Regimen B: two capsules of placebo 30 min before 
chemotherapy, and then one capsule of placebo at 6 h and 12 h 
after chemotherapy on day one and then one capsule of 
metoclopramide (10 mg) was given to patients four times a 
day on day 2 to 5. 
Adding ginger to standard anti-emetic 
regimen did not have any benefit to reduce 
nausea and vomiting in the acute phase and 
also efficacy of ginger and metoclopramide in 
delayed phase did not have any statistically 
significant difference [27] 
 
Randomized study (n =28) 
Control group received normal diet from day 2 to 4. 
Protein group received protein drink and four 250 mg capsules 
of ginger twice a day from day 2 to 4. 
High protein group received protein drink and additional 
protein and four 250 mg capsules of ginger twice a day from 
day 2 to 4. 
High protein meals and ginger reduced the 
delayed phase of nausea following 
chemotherapy [28] 
Randomized, double-blind, placebo-
controlled clinical trial (n = 162) 
Regimen one: 1 g ginger as two capsules and two capsules of 
placebo twice daily for 3 days or 
Regimen two: 2 g ginger as four capsules twice daily for 3 
days or 
Regimen three: matched placebo as four capsules of placebo 
twice daily for 3 days 
Addition of different doses of ginger to 5-HT3 
receptor antagonists and/or aprepitant did not 
have any advantage to reduce prevalence and 
severity of the acute or delayed phases of 
CINV [29] 
Randomized, double-blind, placebo-
controlled clinical trial (n = 57) 
Participants with weights between 20 – 40 kg took 1 g per day 
ginger as 6 capsules of 167 mg ginger or matched placebo 
(starch) for day 1 to 3 of chemotherapy 
Patients with weights between 40 – 60 kg took 2 g per day 
ginger as 5 capsules of 400 mg ginger or matched placebo 
(starch) for day 1 to 3 of chemotherapy 
Ginger is effective as add-on therapy to 
antiemetic medications for reducing CINV in 
children and young adults [30] 
Randomized, double-blind,  
placebo-controlled, multicenter 
clinical trial (n = 576) 
Patients divided in 4 groups (placebo, 0.5 g ginger, 1 g ginger 
and 1.5 g ginger). Three capsules (ginger or placebo) were 
given twice daily for 6 days, started 3 days before 
chemotherapy for 2 cycles 
Ginger at dose of 0.5 g and 1 g per day 
significantly reduced CIN [31] 
A pilot, randomized, and open-label 
clinical Trial (n = 100) 
Ginger (0.5 g three times a day) plus standard antiemetic 
regimen or antiemetic regimen for 4 days after chemotherapy 
Ginger as add-on therapy significantly 
reduced the prevalence of nausea during 6 to 
24 hours after g chemotherapy [32] 
Postoperative Nausea and Vomiting 
Randomized, double-blind, placebo-
controlled study (n = 60) 
Group 1: 1 g ginger orally and placebo injection or 
Group 2: 1 g placebo and 10 mg metoclopramide orallyor 
Group 3: 1 g placebo orally and placebo injection 
Capsule of ginger or placebo were administrated 1.5 hours 
before surgery. Active or placebo injection was given at the 
time of anesthesia induction. 
Ginger significantly reduced postoperative 
nausea and use of antiemetic medications. 
Efficacy of ginger as antiemetic was similar to 
metoclopramide [33] 
Randomized, double-blind, placebo-
controlled study (n = 120) 
Group A: 10 mg metoclopramide (as two capsules), or 
Group B: 1 g powdered ginger (as two capsules), or 
Group C: 1 g lactulose (as two capsules), 1 hour before 
operation. 
Effect of ginger in reducing incidence of 
PONV was similar to metoclopramide. Need 
for postoperative anti-emetics also was lower 
in the ginger group [34] 
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Table 1. contd… 
Type of study (Number of Subjects) Intervention Outcome (Reference) 
Chemotherapy Induced Nausea and Vomiting 
Systematic Review (8 Studies) Oral Ginger No Obvious Conclusion was Drawn [26] 
Randomized, double-blind, placebo-
controlled trial (n = 108) 
Participants were randomly assigned to 1 g ginger  
(as two capsules) or 500 mg ginger (as one capsule)  
and placebo (as one capsule) or placebo (as two capsules)  
1 hour before surgery 
Ginger as 0.5 g or 1 g did not have any 
significant effect on prevention of PONV [35] 
Randomized, double-blind, placebo-
controlled study (n = 120) 
Participants were randomly divided into four groups and 
received either two capsules of placebo orally and 0.5 ml 
normal saline (i.v.) or two capsules of placebo orally and 1.25 
mg droperidol (i.v.) or two capsules of powdered ginger (0.5 g 
per capsule) and 0.5 ml normal saline (i.v.) or two capsules of 
powdered ginger and 1.25 mg droperidol (i.v.). Intravenous 
injection was administrated before induction of anesthesia and 
oral capsules of placebo or ginger were given twice (1 hour 
before operation and 30 min before patients’ discharge) 
Ginger or droperidol or both of them in a 
combination were in-effective for reducing 
PONV [36] 
Randomized, double-blind, placebo-
controlled study (n = 80) 
Participants randomly received 1 g powdered ginger (500 mg 
per capsule) or two capsules of placebo one hour before 
operation 
Ginger was an effective antiemetic for 
prevention of postoperative nausea [37] 
Randomized, placebo-controlled trial 
(n = 184) 
Two capsules of placebo or one capsule of placebo oand one 
capsule of ginger extract (contained 100 mg ginger extract) or 
two capsule of ginger extract were administered three times 
(pre-operation and at 3 and 6 h post-operation) 
There was not any significant difference 
between three groups. Ginger did not have any 
effect in prevention of PONV [38] 
Meta analysis (n = 6 studies) Oral ginger Ginger was not a applicable antiemetic to prevent PONV [39] 
Meta analysis (n = 5 studies) Oral ginger Ginger was an effective antiemetic in preventing PONV [40] 
Randomized, double-blind, placebo-
controlled study (n = 120) 
Participants were randomly assigned to 10 mg oral diazepam 
with 500 mg oral ginger or oral placebo one hour before 
surgery. Dexamethasone (i.v.) was administrated to all 
participants before induction of anesthesia 
Efficacy of ginger plus dexamethasone 
compared to dexamethasone alone as 
prophylactic interventions for PONV did not 
different [41] 
Randomized, double-blind, placebo-
controlled study (n = 120) 
Participants randomly received either 1 g powdered ginger 
(500 mg per capsule) or 1 g placebo (500 mg lactolose per 
capsule) one hour before surgery 
Ginger was an effective anti-emetic for 
prevention of PONV [42] 
Randomized, placebo-controlled study 
(n = 60) 
Patients received 1.5 g of powdered ginger (500 mg per 
capsule) or matched placebo one hour before surgery 
Ginger was effective for prevention of PONV. 
Ginger also showed borderline effect on 
prevention of PONV 
Randomized, double-blind, placebo-
controlled study (n = 120) 
Participants randomly were assigned to receive one of the 
following six interventions: ginger 250 mg (group 1) or 
metoclopramide 10 mg ( group 2) or prochlorperazine 5 mg 
(group 3) or promethazine 20 mg ( group 4) or ondansetron 
4mg ( group 5) or placebo (empty capsule) ( group 6)  
one hour before surgical procedure and then at 8 hour  
intervals for 24 hours 
Ginger was a effective medication for 
prevention of PONV. Severity and incidence 
of nausea and vomiting were lowest than  
other antiemetic medications. Ginger was the 
most cost effective drug in comparison with 
others. Ginger also showed negligible side 
effects [21] 
 
All participants received 5-HT3 receptor antagonists and/or 
aprepitant as needed. Severity and incidence of nausea and 
vomiting were recorded in acute phase by investigators and 
in delayed phase by patients themselves according to the 
Morrow Assessment of Nausea and Emesis. Severity of 
nausea was also assessed by the six-point Likert scale 
through grading from very mild to intolerable. Addition of 
different doses of ginger to 5-HT3 receptor antagonists 
and/or aprepitant did not show any further advantage in 
reducing incidence as well as severity of the acute or delayed 
phases of CINV [22].  
 Effects of ginger as add-on therapy on controlling CINV 
were assessed by Pillai et al. (2011) in 57 children and 
young adults during a randomized, double-blind clinical 
trial. The treatment regimen was high emetogenic 
chemotherapy agents including cisplatin and doxorubicin. 
Patients with body weight between 20-40 kg received 1 g per 
day ginger (6 capsules of 167 mg ginger) or matched placebo 
(starch) from days 1 to 3 of chemotherapy. Patients with 
body weight between 40-60 kg took 2 g per day ginger (5 
capsules of 400 mg ginger) or matched placebo (starch) from 
days 1 to 3 of chemotherapy. All participants received 
ondansetron and dexamethasone as anti-emetics. Patients 
were followed for10 days. Participants recorded severity and 
incidence of nausea and vomiting based on the Edmonton's 
Symptom Assessment Scale. Ginger was effective as add-on 
therapy in controlling CINV in children and young adults 
[23]. 
 Effects of different doses of ginger in controlling the 
acute phase of CIN have been evaluated by Ryan et al. 
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(2012) in a randomized, double-blind, placebo-controlled, 
multicenter clinical trial. In this study, 576 patients received 
chemotherapy were included. Participants were followed for 
three cycles of chemotherapy. The first cycle was considered 
as the baseline cycle. Patients received the interventions 
during the second and third cycles. A 5-HT3 receptor 
antagonist and dexamethasone were administered on day one 
of the cycles and then the patients were assigned into 4 
groups and received placebo, 0.5 g, 1 g, and 1.5 g of ginger 
per day, respectively. Nausea was assessed by the 7-point 
semantic rating scale and the 13-item symptom inventory. 
The latter scale also was used for assessing side effects of 
ginger. Quality of life was evaluated by the 27-item 
Functional Assessment of Chronic Illness Therapy-General. 
Ginger at doses 0.5 g and 1 g per day significantly reduced 
CIN as add-on therapy [24]. 
 In a pilot, randomized, and open-label clinical trial, 
Panahi et al. (2012) studied effects of ginger on the acute 
and delayed phases of CINV. One hundred women with 
breast cancer (under chemotherapy (docetaxel, epirubicin, 
and cyclophosphamide) were entered into the study. 
Participant randomly assigned to ginger (0.5 g three times a 
day) plus standard anti-emetic medications or anti-emetic 
regimen for 4 days following chemotherapy. Incidence and 
severity of nausea and vomiting were determined by the 
Rhodes index in the first 6 hours, during 6 to 24 hours, and 
at days 2 to 4 after chemotherapy. In this study, ginger as 
add-on therapy significantly reduced the incidence of nausea 
within 6 to 24 hours after chemotherapy. No additional 
benefit for ginger was noted in this study [25]. 
 Based on the available evidences, it can be concluded 
that ginger as an anti-emetic herbal medicine with acceptable 
safety profile may be considered as an add-on therapy in 
controlling CINV. The best time of adding ginger to a 
standard anti-emetic regimen, appropriate dose of ginger, 
safety of ginger in patients with cancer, its plausible 
interactions with other anti-emetics and chemotherapeutic 
agents should be investigated in future large randomized 
clinical trials.  
POSTOPERATIVE NAUSEA AND VOMITING 
 PONV is one of the commonest adverse effects of 
general anesthesia. Approximately 30% of surgical patients 
experience PONV [26, 27]. Exact mechanism of PONV is 
unknown. Multiple factors including type of surgery, patient’ 
characteristics (e.g. age and body weight), and type of 
anesthesia are involved. Pre-anesthetic medications such as 
opioids and some anesthetic agents such as nitrous oxide 
increase the incidence of PONV [28, 29]. Different types of 
receptors (dopaminergic, histaminergc, muscarinic, 
serotonergic, cholinergic, and opioid) are related to PONV 
[28, 30]. Different classes of medications have been 
exploited for controlling PONV. Usually three or more 
medications are administered to manage PONV. 
Combination therapy with different mechanisms increases 
the efficacy of PONV management. Adverse effects of these 
regimens are also an important issue [26, 27, 31].  
 Ginger blocks several receptors involving in the 
pathogenesis of CINV and PONV [12, 30-32]. Some studies 
have been conducted to evaluate the effect of ginger in 
prevention and treatment of PONV. Most of these studies 
have assessed effects of ginger in gynecological surgeries in 
women. Bone et al. (1990) compared the efficacy of ginger 
as an anti-emetic with placebo and metoclopramide in a 
randomized, double-blind study. Sixty women undergone 
major gynecological surgeries were recruited. Patients were 
randomly divided into 3 groups. Group one received 1 g 
ginger orally (each capsule contained 500 mg powdered 
ginger) and 2 ml i.v. sterile water as placebo. Group two 
took 1 g lactulose orally as placebo and 10 mg 
metoclopramide as i.v. injection. One gram oral placebo and 
2 ml i.v. placebo were administered for group three. Oral 
ginger or placebo was administrated 1.5 hours before 
surgery. Active or placebo injection was given at the time of 
anesthesia induction. Anesthesia was induced by 
thiopentone, alcuronium or vecuronium, nitrous oxide, and 
enflurane. Papaveretum was applied as an analgesic agent. 
Severity and incidence of nausea and vomiting were 
recorded by the investigators in the recovery room and at 6, 
12 and 24 hrs of post-operation. Severity of nausea was 
graded from mild to severe. Based on results of this study, 
ginger significantly reduced post-operative nausea and need 
for additional anti-emetic medications. In addition, the anti-
emetic effects of ginger were comparable to metoclopramide 
[33]. 
 The results of a prospective, randomized, double-blind 
trial in 120 women following laparoscopic gynecological 
surgery have been reported by Phillips et al. (1993). 
Participants were divided into 3 groups. They randomly 
received either 10 mg metoclopramide (group A), 1 g 
powdered ginger (group B), or 1 g lactulose (group C) orally 
one hour before the operation. Anesthesia was induced by 
propofol, fentanyl, atracurium, isoflurane, and nitrous oxide. 
Paracetamol, codydramol, and pethidine were used as 
analgesic agents. Incidence of nausea and vomiting were 
recorded during recovery phase, 24 h post-operation and at 
hospital discharge. In this study, ginger was as effective as 
metoclopramide in reducing the incidence of PONV. The use 
of postoperative anti-emetics was also significantly lower in 
the ginger group [34]. 
 In opposite to early studies, ginger did not show 
significant beneficial effects in prevention of PONV in more 
recent clinical trials. Arfeen et al. (1995) conducted a 
double-blind, randomized, placebo-controlled trial in 108 
patients undergoing gynecological laparoscopic surgery to 
investigate the efficacy of ginger for prevention of PONV. 
Participants were randomly assigned to either 1 g ginger (as 
two capsules) or 500 mg ginger (as one capsule) plus 
placebo (as one capsule) or placebo (as two capsules) groups 
one hour before surgery. Thiopentone, vecuronium, 
enflurane, and nitrous oxide were used for induction of 
anesthesia. Morphine was administered as intra-operative 
analgesic agent. Patients were followed regarding incidence 
and severity of PONV during 3 hours post-operation. 
Severity of nausea was graded from 0 to 3 and vomiting was 
scored from 0 to 1. In this study, ginger at doses 0.5 or 1 g 
did not show any significant effect in preventing PONV [35].  
 Effects of ginger and droperidol in reducing PONV were 
compared in a randomized, double-blind placebo-controlled 
study. In this study, Visalyaputra et al. (1998) recruited 120 
women undergone diagnostic gynecological laparoscopic 
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surgery. Participant were randomly divided into four groups 
and received either two capsules of placebo orally and 0.5 ml 
normal saline (i.v.); two capsules of placebo orally and 1.25 
mg droperidol (i.v.); two capsules of powdered ginger (0.5 g 
per capsule) and 0.5 ml normal saline (i.v.); or two capsules 
of ginger and 1.25 mg droperidol (i.v.). Injections were 
performed before induction of anesthesia and oral agents 
were administered one hour before operation and 30 min 
before hospital discharge. Anesthesia was induced by 
thiopentone, fentanyl, suxamethonium, atracorium, nitrous 
oxide, and halothane. Paracetamol tablets were used for pain 
relief. Severity categorized from 0 to 3 and frequency of 
nausea and vomiting were recorded in the recovery room and 
during 24 hours of hospital discharge by a trained nurse. In 
this study, ginger, droperidol, and their combination were 
not effective in reducing PONV [36]. 
 Pongrojpow et al. (2003) investigated the effect of ginger 
on prevention of PONV after outpatient gynecological 
laparoscopy in a randomized, double-blind, placebo-
controlled study. Eighty patients were randomly received 
either 1 g powdered ginger (500 mg per capsule) or two 
capsules of placebo one hour before operation. Frequency of 
nausea measured by the visual analogue nausea scale and 
vomiting were recorded at 2, 4, 24 hour of post-operation. 
Ginger was effective in preventing of nausea but frequency 
of vomiting was not significantly different between the two 
groups [37]. 
 Effect of ginger extract on the post-operative patients’ 
satisfaction was assessed during a randomized, placebo-
controlled trial in 184 healthy women undergone 
gynecologic laparoscopy by Eberhart et al. (2003). Patients 
were randomly allocated into three groups. Included patients 
received either two capsules of placebo, one capsule of 
placebo and one capsule of ginger (contained 100 mg ginger 
extract) or two capsules of ginger three times ( pre-operation 
and 3 and 6 h of post-operation). General anesthesia  
was induced by propofol, fentanyl, atracurium or, 
succinylcholine, desflurane, and nitrous oxide. Piritramid 
was used for pain relief. Incidence of nausea and vomiting 
were recorded at 1, 2, 6, and 24 h after surgery. There was no 
significant difference between three groups regarding 
incidence of nausea and vomiting. Ginger did not show any 
beneficial effect in the prevention of PONV [38]. 
 Morin et al. (2004) conducted a meta- analysis (2004) to 
determine the efficacy of ginger for prevention of PONV. 
Six randomized controlled clinical trials were included in 
this analysis. They concluded that ginger is not an effective 
anti-emetic agent for prevention of PONV [39]. However in 
the later meta-analysis performed by Chaiyakunapruk et al. 
(2006) which included 5 randomized, placebo-controlled 
trials, it was concluded that ginger is an effective antiemetic 
in preventing PONV. Ginger can to be used at least as the 
add-on therapy in controlling PONV considering its 
availability, being inexpensive and desirable side effects 
[40]. 
 Other surgical procedures were also considered to 
evaluate preventive effect of ginger on PONV. Tavlan et al. 
(2006) compared anti-emetic effect of ginger plus 
dexamethasone with dexamethasone alone in preventing 
PONV in a randomized, placebo-controlled trial. In this 
study, 120 patients undergone thyroidectomy surgery were 
recruited. Participants were randomly assigned to receive 
either 10 mg oral diazepam plus 500 mg ginger or placebo 
one hour before surgery. Dexamethasone (i.v.) was 
administrated for all participants before induction of 
anesthesia. Propofol, fentanyl, atracurium, isoflurane, and 
nitrous oxide were used for induction of general anesthesia. 
Fentanyl also was used for control of postoperative pain. A 
four-point scale was used to assess incidence of PONV. The 
severity of nausea was evaluated by a numerical scale and 
graded from 0 to 2. Patients were followed during the first  
24 h of surgery. Adding ginger to dexamethasone as a 
prophylactic intervention for PONV did not show further 
benefit compared to dexamethasone alone [41]. 
 Nanthakomon et al. (2006) investigated the effect of 
ginger on preventing PONV after major gynecological 
surgeries in a randomized, double-blind, placebo-controlled 
study. One hundred and twenty patients randomly received 
either 1 g ginger (500 mg per capsule) or 1 g placebo (500 
mg lactulose per capsule) one hour before surgery. 
Anesthesia was induced by thiopental, alcuronium, or 
vecuronium. Diclofenac was used for postoperative pain 
control. Frequency of nausea (measured by the visual 
analogue scale) and vomiting (direct questioning) were 
recorded at 0, 2, 6, 12 and 24 h after surgery by 
investigators. Frequency of nausea and vomiting was 
significantly lower in the ginger compared to the placebo 
group. The results supported preventive role of ginger for 
PONV [42]. 
 Findings of a randomized, placebo-controlled study in 60 
patients undergone elective gynecological laparoscopy have 
been reported by Apariman et al. in 2006. Patients randomly 
received either 1.5 g of powdered ginger (500 mg  
per capsule) or matched placebo 1 hour before surgery. 
Participants recorded nausea symptoms (based on the visual 
analogue scale) and a trained physician recorded frequency 
of vomiting at 2 and 6 h after surgery. Opioids were used for 
pain relief as needed. In this study, ginger showed a 
borderline effect in prevention of PONV. Nausea symptoms 
were lower at 2 h than 6 h after operation. This effect may be 
attributed to pain and use of opioids for pain relief during the 
recovery phase [43]. 
 Results of comparing ginger efficacy with other classic 
anti-emetics in prevention of PONV are interesting. Nale et al. 
(2007) compared the effectiveness of ginger in preventing 
PONV with other anti-emetic medications in a randomized, 
double-blind, placebo-controlled clinical trial. In this study, 
120 patients undergone non-emergency surgical procedures 
were randomly assigned to one of the following six 
interventions including ginger 250 mg (group 1), 
metoclopramide 10 mg (group 2), prochlorperazine 5 mg 
(group 3), promethazine 20 mg (group 4), ondansetron 4mg 
(group 5) or empty capsule as placebo (group 6) one hour 
before surgical procedure and then at 8-hour intervals for 24 
hours. Thiopenlone, nitrous oxide, halothane, and 
pentazocine were used as anesthetic agents. Patients were 
monitored for 48 hours. Severity of nausea (measured by the 
visual analogue scale) and frequency of vomiting were 
assessed in three periods (0-6, 6-24, and 24-48 h of post-
operation). Cost and side effects of the medications were 
also assessed. Ginger was a very effective intervention in 
preventing PONV and severity and incidence of nausea and 
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vomiting were lowest in the ginger group compared with 
other antiemetic medications. Also ginger was the most cost 
effective intervention with negligible adverse effects [21]. 
 There are some conflicting issues regarding efficacy of 
ginger in prevention of PONV. Most of the relevant studies 
included gynecological surgeries and women population. 
Also types of surgeries (open or laparoscopic intervention), 
anesthetic agents, and analgesics that can affect incidence of 
PONV were different in most studies. Other issues are dose 
and time of ginger administration and duration of patients’ 
follow-up. Administration of oral anti-emetic agent in pre-
operation phase for patients not allowed to take anything per 
oral is another challenging issue. Designing well-controlled 
studies for determining the best dose, rout and time of ginger 
administration for various types of surgeries are essential. 
Based on the available evidences, it seems that ginger may 
be an effective agent in preventing PONV.  
CONCLUSION 
 The rhizome of Zingiber officinale has been used as 
botanical remedy for controlling nausea and vomiting for 
more than 2500 years (4). Ginger blocks M3, 5-HT3 and 5-
HT4, and NK1 receptors at peripheral and central levels 
involved in the pathogenesis of CINV and PONV [6, 7, 22]. 
The adverse effects of conventional medications used for 
managing PONV and CINV are considerable issues [12, 18]. 
The current medications do not have optimal efficacy to 
control PONV and CINV [17, 19]. Ginger does not have 
significant adverse effects, drug-interactions and also is a 
cheap agent [2, 25]. It seems that ginger has beneficial 
effects in prevention and treatment of CINV and PONV. 
Various studies evaluated effect of ginger in prevention and 
management of nausea and vomiting in different conditions 
such as pregnancy, CINV, and PONV. Evidences regarding 
anti-emetic effect of ginger in prevention and treatment of 
CINV are limited. More randomized clinical trials should be 
conducted to confirm the efficacy of ginger in this regards. 
Ginger showed promising and attractive effect on preventing 
PONV at least as add-on therapy. The exact role of ginger as 
an anti-emetic agent in prevention of PONV should be 
elucidated in future large randomized clinical trials.  
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